Body High
The bodily, physical component of a cannabis experience: heaviness, relaxation, and reduced pain awareness.
Body high and head high are consumer shorthand for different subjective experiences, not technical pharmacology terms. Higher doses, edibles, and lower tolerance tend to shift experiences toward physical effects. But the popular idea that strain name or terpene profile reliably predicts this is marketing folklore. Your dose, tolerance, and individual neurobiology matter far more than the label.
Definition
A body high is the physical component of a cannabis experience: heavy or numb limbs, muscle relaxation, warmth, tingling, sedation, reduced pain awareness, and a general pull toward stillness and immobility. It is contrasted with a head high or cerebral high, which describes cognitive and perceptual effects like euphoria, racing thoughts, time distortion, or altered visual perception.
The terms are descriptive shorthand used by consumers, budtenders, and product reviewers — they do not appear in pharmacology or neuroscience textbooks and have no formal clinical definition.
What probably causes it
The honest answer: the specific mechanisms are not yet fully understood. THC binds to CB1 receptors throughout the central and peripheral nervous system. At higher doses, THC produces increasingly pronounced sedative, motor-slowing, and analgesic effects Strong evidence[1]. This dose-dependent shift toward physical sedation is well documented.
Several factors appear to push experiences toward the body-dominant end:
- Higher doses: Larger amounts of THC increase motor and cognitive slowing Strong evidence[1][2][3].
- Edibles: Oral cannabis is metabolized by the liver to 11-hydroxy-THC, a metabolite with a longer duration and reportedly more physical/sedating character Strong evidence[2].
- Lower tolerance: Infrequent users report more pronounced sedative effects at the same dose as regular users Strong evidence[3].
- CBD-rich products: CBD does not bind strongly to CB1 receptors and is often reported as producing less intoxication and a more relaxing, body-leaning experience Weak / limited[4]. The mechanism remains unclear.
Terpenes and other minor cannabinoids likely contribute to subjective character, but their role is poorly characterized in controlled human studies Weak / limited[5].
What it isn't
Popular explanations for body highs often lack scientific support:
- "Indicas give body highs, sativas give head highs." Strain morphology (indica vs sativa plant shape) does not reliably predict effects. Chemotype (cannabinoid and terpene profile) is a better predictor, but even chemotype explains only a fraction of the variance in subjective experience Disputed[6][7]. Strain name is unreliable; the same name may refer to very different plants across growers and regions.
- "Myrcene above 0.5% makes it a body high." This specific threshold is internet folklore. There is no peer-reviewed evidence supporting a 0.5% myrcene threshold as a predictor of body-dominant effects No data.
- "It's all about the terpenes." Terpenes likely influence subjective effects, but the "entourage effect" (the idea that cannabis compounds synergize in predictable ways) remains poorly characterized and inconsistently demonstrated in controlled human studies Weak / limited[5].
A body high is also distinct from sedation, couch-lock, or being stoned — related but separate descriptions of subjective state.
How the term is used
You will encounter "body high" in strain reviews, dispensary product descriptions, and marketing materials, typically used as a positive label for evening, pain-relief, sleep, or relaxation products.
Treat the label as a hint about the typical reported experience at typical doses in typical users — not a reliable guarantee for you specifically. Your dose, individual tolerance, body composition, food intake, set and setting, and neurobiological variation will shift your experience far more than the strain name or cannabinoid profile on the jar.
If a specific effect or outcome matters to you (sleep, pain relief, anxiety reduction), look first to peer-reviewed clinical trial results and dosing information, then consider individual reports as secondary evidence.
Sources
- Peer-reviewed Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016). Keep off the grass? Cannabis, cognition and addiction. Nature Reviews Neuroscience, 17(5), 293–306.
- Peer-reviewed Lemberger, L., Crabtree, R. E., & Rowe, H. M. (1972). 11-Hydroxy-Δ9-tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man. Science, 177(4043), 62–64.
- Peer-reviewed Schlienz, N. J., Spindle, T. R., Cone, E. J., Herrmann, E. S., Bigelow, G. E., Mitchell, J. M., Flegel, R., LoDico, C., & Vandrey, R. (2020). Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis. Drug and Alcohol Dependence, 211, 107969.
- Peer-reviewed Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199–215.
- Peer-reviewed Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
- Peer-reviewed Sawler, J., Stout, J. M., Gardner, K. M., Hudson, D., Vidmar, J., Butler, L., Page, J. E., & Myles, S. (2015). The genetic structure of marijuana and hemp. PLoS ONE, 10(8), e0133292.
- Peer-reviewed Vergara, D., Bidwell, L. C., Gaudino, R., Torres, A., Du, C., Ruthenburg, T. C., Mendelson, J. E., Janowsky, A., & Kane, N. C. (2017). Compromised external validity: federally produced cannabis does not reflect legal markets. Scientific Reports, 7, 46528.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cerebral High — A mentally stimulating cannabis experience, distinct from physical sedation.
- Head High — Mental and emotional effects of cannabis, distinguished from sedative or physical sensatio...
- Mental Relaxation — Reduced cognitive arousal and worry; dose-dependent, not strain-predictable, distinct from...
- Physical High — Subjective body-focused cannabis effects; no lab test distinguishes them from cognitive ef...
- Tolerance Break (T-Break) — A period of cannabis abstinence to restore THC sensitivity through CB1 receptor recovery.